Incentives for early declaration and effective prevention of avian influenza in the Mekong

What we aim to achieve:

Insight into policies that promote protection against Highly Pathogenic Avian Influenza, with a focus on poultry owners’ livelihoods.

How we will achieve it:

By undertaking a series of key informant interviews with 5-8 government officials in Vietnam, Cambodia and Laos.

Partners:

  • Nossal Institute for Global Health, Australia
  • Peter Doherty Institute for Infection and Immunity, Australia
  • University of Sydney, Australia
  • Health Strategy and Policy Institute, Vietnam
  • Pasteur Institute, Ho Chi Minh City, Vietnam
  • Hanoi University of Public Health, Vietnam
  • National Institute of Public Health, Cambodia
  • Pasteur Institute, Cambodia
  • Lao Tropical and Public Health Institute
  • Pasteur Institute, Laos
  • Luxembourg Institute of Health, Luxembourg

Where:

Vietnam, Cambodia and Laos

Funding: $250,000 co-funded by ACIAR and DFAT.

Highly Pathogenic Avian Influenza (H5N1) is of particular concern as an emerging infectious diseases because its case fatality rate has risen from 33% to 82% in recent outbreaks. A large outbreak would likely have severe consequences. Vietnam, Cambodia and Laos have all been sites of outbreaks resulting in human infection. The virus passes between wild birds and domestic poultry including geese, ducks and chickens.

This project will focus on researchin policies that promote protection against Highly Pathogenic Avian Influenza in Vietnam, Cambodia and Laos with the ultimate aim of designing policies that align with stakeholder’s objectives and incentives. For example, the project team will seek to understand how poultry owners understand interactions between themselves and their poultry’s health, as well as what actions they may take. They will do this by undertaking a series of key informant interviews with 58 government officials in each country, and by collecting and reviewing relevant documentation of current policies.

Chief Investigator: 

Dr Barbara McPake (Nossal Institute for Global Health)